logo
  

BD Buys Tissuemed - Quick Facts

Becton, Dickinson and Company (BDX) has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England developing self-adhesive surgical sealant films. Tissuemed's lead product, Tissuepatch, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions.

Kevin Kelly, president of Surgery for BD, said: "Integrating Tissuepatch into our business aligns with our commitment to continuously innovate in our core portfolio to help support minimally invasive surgeries."

The company said the acquisition expands its global offerings for surgeons outside of the U.S. It expects transaction to be immaterial to fiscal 2022 results.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT